Shanghai Allist Pharmaceuticals Co., Ltd. (SHA:688578)
79.98
-1.58 (-1.94%)
Nov 17, 2026, 3:00 PM CST
SHA:688578 Revenue
Shanghai Allist Pharmaceuticals had revenue of 1.82B CNY in the quarter ending September 30, 2026, with 33.58% growth. This brings the company's total for the last twelve months to 6.59B, up 38.51% year-over-year. In the year 2025, Shanghai Allist Pharmaceuticals had annual revenue of 5.19B with 45.80% growth. That makes Shanghai Allist Pharmaceuticals the 7,685th largest company in the world by revenue and 1,132nd in China.
Revenue (ttm)
6.59B
Revenue Growth
+38.51%
P/S Ratio
5.46
Revenue / Employee
3.31M
Employees
2,272
Market Cap
35.99B
Revenue by Geography
- China 5.15B 99.3%
- Overseas 35.00M 0.7%
Fiscal year ended Dec 31, 2025 See the full SHA:688578 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.19B | 1.63B | 45.80% |
| Dec 31, 2024 | 3.56B | 1.54B | 76.29% |
| Dec 31, 2023 | 2.02B | 1.23B | 155.14% |
| Dec 31, 2022 | 791.00M | 260.91M | 49.22% |
| Dec 31, 2021 | 530.09M | 529.53M | 94,409.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Pharmaron Beijing | 16.01B |
| Chongqing Zhifei Biological Products | 7.85B |
| Asymchem Laboratories (Tianjin) | 7.44B |
| Shanghai RAAS Blood Products | 6.20B |
| Haisco Pharmaceutical Group | 6.06B |
| Beijing Tiantan Biological Products | 5.56B |
| Sunshine Guojian Pharmaceutical (Shanghai) | 4.48B |
| Xiamen Amoytop Biotech | 3.95B |
Shanghai Allist Pharmaceuticals News
- 20 days ago - Shanghai Allist Pharmaceuticals Quarterly report: Q3 2026 - Filings
- 3 months ago - Shanghai Allist Pharmaceuticals Quarterly report: Q2 2026 - Filings
- 6 months ago - Shanghai Allist Pharmaceuticals Quarterly report: Q1 2026 - Filings
- 7 months ago - Shanghai Allist Pharmaceuticals Annual report: Q4 2025 - Filings